National Peroxide Limited (BOM:544205)
502.70
-0.30 (-0.06%)
At close: Nov 17, 2026
National Peroxide Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
| 3,631 | 2,897 | 2,869 | 3,330 | |
Revenue Growth | 34.09% | 0.99% | -13.85% | - |
Cost of Revenue | 2,586 | 1,978 | 2,075 | 2,227 |
Gross Profit | 1,046 | 918.73 | 793.78 | 1,103 |
Selling, General & Admin | 290.94 | 265.18 | 304.41 | 292.75 |
Other Operating Expenses | 430.69 | 411.15 | 337.27 | 434.45 |
Operating Expenses | 933.13 | 884.23 | 842.76 | 919.8 |
Operating Income | 112.45 | 34.5 | -48.98 | 183.32 |
Interest Expense | -11.47 | -13.55 | -16.65 | -19.82 |
Interest & Investment Income | 10.27 | 10.27 | 6.64 | 5.14 |
Currency Exchange Gain (Loss) | 26.96 | 26.96 | 4.05 | 6.03 |
Other Non Operating Income (Expenses) | 3.55 | 3.55 | 9.92 | 12.9 |
EBT Excluding Unusual Items | 141.77 | 61.74 | -45.03 | 187.57 |
Gain (Loss) on Sale of Investments | 18.94 | 18.94 | 24.26 | 25.43 |
Gain (Loss) on Sale of Assets | - | - | - | 2.13 |
Other Unusual Items | -5.82 | -5.82 | - | - |
Pretax Income | 154.89 | 74.86 | -20.77 | 215.14 |
Income Tax Expense | 34.62 | 16.61 | 1.7 | 47.24 |
Net Income | 120.28 | 58.24 | -22.46 | 167.9 |
Net Income to Common | 120.28 | 58.24 | -22.46 | 167.9 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 |
Shares Change | -0.02% | - | - | - |
EPS (Basic) | 20.93 | 10.13 | -3.91 | 29.22 |
EPS (Diluted) | 20.93 | 10.13 | -3.91 | 29.22 |
EPS Growth | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Free Cash Flow | 132.72 | 297.91 | 137.78 | 217.7 |
Free Cash Flow Per Share | 23.09 | 51.84 | 23.97 | 37.88 |
Dividend Per Share | - | 7.000 | - | 12.500 |
Dividend Growth | - | - | - | - |
Gross Margin | 28.79% | 31.71% | 27.67% | 33.13% |
Operating Margin | 3.10% | 1.19% | -1.71% | 5.50% |
Profit Margin | 3.31% | 2.01% | -0.78% | 5.04% |
Free Cash Flow Margin | 3.65% | 10.28% | 4.80% | 6.54% |
EBITDA | 315.48 | 233.92 | 145.24 | 367.33 |
EBITDA Margin | 8.69% | 8.07% | 5.06% | 11.03% |
D&A For EBITDA | 203.03 | 199.42 | 194.22 | 184.01 |
EBIT | 112.45 | 34.5 | -48.98 | 183.32 |
EBIT Margin | 3.10% | 1.19% | -1.71% | 5.50% |
Effective Tax Rate | 22.35% | 22.20% | - | 21.96% |
Revenue as Reported | 3,691 | 2,957 | 2,914 | 3,381 |